Search

Author/Creator Evans, J.W.

1. Enhancement of anti-tumor immunity in immunogenic and immune-refractory RAS mutant tumors with tri-complex RAS(ON) inhibitors. (October 2022)

Authors:
Blaj, C.; Menard, M.; Tobvis Shifrin, N.; Chen, K.; Chow, C.; Courtney, H.; Kumamoto, A.; Velilla, T.; Evans, J.W.; Lawrence, L.; Vonmelchert, B.; Kwok-Parkhill, A.; Singh, M.; Smith, J.A.; Quintana, E.
Journal:
European journal of cancer
Issue:
Volume 174(2022)Supplement 1
Page Start:
S59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Optimal therapeutic positioning of a selective bi-steric inhibitor of MTORC1 in genetically defined cancers. (October 2020)

Authors:
Jiang, J.; Yang, Y.C.; Schulze, C.J.; Evans, J.W.; Wang, Z.C.; Lee, B.J.; Choy, T.J.; Reyes, D.F.; Zhao, R.P.; Tao, J.Y.; Du, H.; Ozawa, T.; Wildes, D.P.; Raleigh, D.R.; Wang, Z.P.; Monga, S.P.; Kwiatkowski, D.J.; Weiss, W.A.; Smith, J.A.; Singh, M.
Journal:
European journal of cancer
Issue:
Volume 138(2020)Supplement 2
Page Start:
S53
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search